Travere Therapeutics, Inc.
Extract: Bylaws Amended/Restated (Plain English Desc) from a 8-K on 11/16/2020   Download
SEC Document
SEC Filing
Effective November 13, 2020, we changed our name from “Retrophin, Inc.” to “Travere Therapeutics, Inc.” by filing a certificate of amendment (“Certificate of Amendment”) to our Certificate of Incorporation with the Secretary of State of the State of Delaware. We also amended and restated our bylaws to reflect the change to our name, effective November 13, 2020.